Taysha's Chief Sold $1.2: What It Means for Investors
An insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
This intro asks which is better for beginners in 2026: manual or robo investing, covering simplicity, risk, and learning curve for new investors.
25,920 articlesAn insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
When biotech headlines hit, stocks can swing quickly. Here’s a grounded look at why stock skyrocketed today for Q32 B...
Lofty and Showami roll out a direct integration that enables on-demand showings within the Lofty CRM, aiming to speed...
CHLA pushes for an FHA pilot that would pay lenders directly for sub-$100K mortgages, arguing the move is needed to u...
Stocks ended mixed as the Dow stayed relatively calm while Nasdaq slipped. Earnings, rates, and sector rotation shape...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
An external review shows the Gates Foundation met with Jeffrey Epstein roughly 30 times between 2011 and 2014, despit...
A broad rally in nuclear stocks helped Constellation Energy ride the wave. This piece breaks down the catalysts, what...
After June 5 volatility unsettles tech stocks, investors are turning to a dividend-focused chip index for steady inco...
Celebrity rumors can ripple into real-life money decisions. This piece uses the kardashian lewis hamilton marriage ch...
AI memory demand is reshaping a sleepy sector. Learn how to gain exposure to Samsung, Hynix, and Micron with a smart,...
Celebrity headlines grab attention, but the real story is how money moves in the face of uncertainty. This guide tran...